| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
FPS-ZM1
|
945714-67-0 |
N-BENZYL-4-CHLORO-N-CYCLOHEXYLBENZAMIDE
|
CS-2304;FPS-ZM1;4-氯-N-环己基-N-(苯基甲基)苯甲酰胺
|
C20H22ClNO |
327.84778 | |
|
moclobemide
|
71320-77-9 |
吗氯贝胺
|
4-氯-N-[2-(4-吗啉基)乙基]苯甲酰胺;吗啉氯酰胺;莫罗酰胺;马氯贝胺;吗氯贝胺,4-氯-N-2-(5-吗啉基)乙基丁苯甲酰胺;吗氯贝胺(标准品);吗氯贝胺
|
C13H17N2O2Cl |
268.73928 | |
|
RS-1
|
312756-74-4 |
4-溴-N-(4-溴苯基)-3-[[(苯基甲基)氨基]磺酰基]苯甲酰胺
|
大鼠皮肤成纤维样细胞;4-溴-N-(4-溴苯基)-3-[[(苯基甲基)氨基]磺酰基]苯甲酰胺
|
C20H16Br2N2O3S |
524.22564 | |
|
(S)-2-amino-3-(4-benzoylphenyl)propanoic acid
|
104504-45-2 |
4-苯甲酰基-L-苯基丙氨酸
|
L-对苯甲酰基苯丙氨酸;4-苯甲酰基-L-苯基丙氨酸;4-苯甲酰基-L-苯丙氨酸;4-苯甲酰基-苯丙氨酸;L-4-BENZOYLPHENYLALANINE 1G
|
C16H15NO3 |
269.3 | |
|
Dasatinib
|
302962-49-8 |
达沙替尼
|
达沙替尼无水物(N-6晶型)大粒径(D50=30-60);达沙替尼无水物(N-6晶型)粉末状;5-噻唑甲酰胺,N-(2-氯-6-甲基苯基)-2-[[6-[4-(2-羟基乙基)-1-哌嗪基]-2-甲基-4-嘧啶基]氨基]-;DASA锡IB;BMS-354825;SPRYCEL;25MG;100MG;1G;达沙替尼 D9
|
C22H28ClN7O3S |
488.01 | 801-607-0 |
|
AZM-475271
|
476159-98-5 |
476159-98-5
|
AZM-475271;M475271;M-475271
|
C23H27ClN4O3 |
442.9443 | |
|
CP 154526 hydrochloride
|
257639-98-8 |
N-丁基-N-乙基-2,5-二甲基-7-(2,4,6-三甲基苯基)-7H-吡咯[2,3-D]嘧啶-4-胺盐酸盐
|
N-丁基-N-乙基-2,5-二甲基-7-(2,4,6-三甲基苯基)-7H-吡咯[2,3-D]嘧啶-4-胺盐酸盐
|
C23H33ClN4 |
400.98792 | |
|
INCB024360
|
914471-09-3 |
4-氨基-N-(3-氯-4-氟苯基)-N'-羟基-1,2,5-恶二唑-3-甲脒
|
4-氨基-N-(3-氯-4-氟苯基)-N'-羟基-1,2,5-恶二唑-3-甲脒;CS-1034;INCB-024360;INCB 024360;INCB-24360;INDOLEAMINE-2;3-DIOXYGENASE INHIBITOR INCB024360;(E)-4-氨基-N-(3-氯-4-氟苯基)-N'-羟基-1,5-二唑-3-甲脒;INCB 024360 类似物;INCB024360 ANALOGUE;IDO5L;INCB024360 500MG;(E)-4-氨基-N'-(3-氯-4-氟苯基)-N-羟基-1,5-恶二唑-3-甲脒
|
C9H7ClFN5O2 |
271.6355832 | |
|
Cytarabine
|
147-94-4 |
阿糖胞苷
|
阿糖胞苷(标准品);CUTOSINE Β-D-阿糖胞苷;阿糖胞嘧啶(阿糖胞苷);4-氨基-1-Β-D-阿拉伯呋喃糖基-2(1H)-嘧啶酮;胞嘧啶-Β-D-呋喃阿拉伯糖苷,ARA-C;1-beta-D-阿拉伯呋喃糖基-4-氨基-2(2H)-嘧啶酮;阿糖胞苷
|
C9H13N3O5 |
243.22 | 205-705-9 |
|
N-(Carbamoylmethyl)taurine
|
7365-82-4 |
N-(2-乙酰胺基)-2-氨基乙磺酸
|
ACES BUFFER(ACES缓冲液),0.5M,PH7.4;ACES BUFFER(ACES缓冲液),PH7.0;ACES BUFFER(ACES缓冲液),PH6.5;ACES BUFFER(ACES缓冲液),PH6.0;N-(2-乙酰氨基)-2氨基乙磺酸;N-(2-乙酰胺基)-2-氨基乙磺酸;N-(氨基甲酰甲基)-2-氨基乙磺酸;N-(2-乙酰氨基)-2-氨基乙磺酸[生物研究用GOOD'S缓冲液中的成分]
|
C4H10N2O4S |
182.2 | 230-908-4 |
|
JNJ-10397049
|
708275-58-5 |
N-(2,4-DIBROMOPHENYL)-N'-[(4S,5S)-2,2-DIMETHYL-4-PHENYL-1,3-DIOXAN-5-YL]-UREA
|
JNJ-10397049;JNJ-10397049, CID 9869934;1-(2,4-dibromophenyl)-3-[(4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl]urea
|
C19H20Br2N2O3 |
||
|
NEURODYE GH4-64
|
162112-35-8 |
NEUROTRANSRED C2 [N-(3-TRIETHYLAMMONIUMPROPYL)-4-(6-(4-DIETHYLAMINO)PHENYL)HEXATRIENYL)PYRIDINIUM DIBROMIDE],&NBSP FM® 4-64 IS TM OF MOLECULAR PROBES;N-(3-TRIETHYLAMMONIOPROPYL)-4-(6-(4-(DIETHY
|
NEUROTRANSRED(监测神经肌肉连接处突触活性);NEUROTRANSRED C2[N-(3-TRIETHYLAMMONIUMPROPYL)-4-(6-(4-DIETHYLAMINO)PHENYL)HEXATRIENYL)PYRIDINIUM DIBROMIDE],&NBSP FM4-64 IS TM OF MOLECULAR PROBES;N-(3-TRIETHYLAMMONIOPROPYL)-4-(6-(4-(DIETHY;NEUROTRANSRED C2 [N-(3-TRIETHYLAMMONIUMPROPYL)-4-(6-(4-DIETHYLAMINO)PHENYL)HEXATRIENYL)PYRIDINIUM DIBROMIDE],&NBSP FM® 4-64 IS TM OF MOLECULAR PROBES;N-(3-TRIETHYLAMMONIOPROPYL)-4-(6-(4-(DIETHY;NEUROTRANSRED C2 [N-(3-TRIETHYLAMMONIUMPROPYL)-4-(6-(4-DIETHYLAMINO)PHENYL)HEXATRIENYL)PYRIDINIUM DIBROMIDE],FM[R] 4-64 IS TM OF MOLECULAR PROBES
|
C30 H45 Br2 N3 |
607.51 | |
|
UNC 0646
|
1320288-17-2 |
N-(1-环己基-4-哌啶基)-2-[六氢-4-异丙基-1H-1,4-二氮杂卓-1-基]-6-甲氧基-7-[3-(1-哌啶基)丙氧基]-4-喹唑啉胺
|
N-(1-环己基-4-哌啶基)-2-[六氢-4-异丙基-1H-1,4-二氮杂卓-1-基]-6-甲氧基-7-[3-(1-哌啶基)丙氧基]-4-喹唑啉胺;UNC 0646;UNC0646;UNC-0646
|
C36H59N7O2 |
621.89936 | |
|
DEFEROXAMINE MESYLATE
|
138-14-7 |
去铁铵
|
甲磺酸去铁胺;去铁胺;去铁胺甲磺酸酯;去铁铵;甲磺酸去铁胺;甲磺酸去铁敏;甲磺酸除铁灵;DEFEROX胺甲磺酸盐;去铁铵;去铁敏
|
C26H52N6O11S |
656.79 | 205-314-3 |
|
EHop-016
|
1380432-32-5 |
EHOP-16;N4-(9-ETHYL-9H-CARBAZOL-3-YL)-N2-(3-MORPHOLIN-4-YL-PROPYL)-PYRIMIDINE-2,4-DIAMINE
|
EHOP-016;N4-(9-ETHYL-9H-CARBAZOL-3-YL)-N2-(3-MORPHOLIN-4-YL-PROPYL)-PYRIMIDINE-2,4-DIAMINE;N4-(9-乙基-9H-咔唑-3-基)-N2-[3-(4-吗啉基)丙基]-2,4-嘧啶二胺;EHOP 016;EHOP016
|
C25H30N6O |
430.5453 | -0 |
|
Beta-Lapachone
|
4707-32-8 |
3,4-二氢-2,2-二甲基-2H-萘并[1,2-B]吡喃-5,6-二酮
|
3,4-二氢-2,2-二甲基-2H-萘并[1,2-B]吡喃-5,6-二酮;BETA-兰帕科恩.BETA-拉帕醌;Β-LAPACHONE;Β-拉巴醌;BETA-拉帕醌;BETA-兰帕科恩;ARQ-501;NSC-26326;NSC-629749;SL-11001;BETA-LAPACHONE;Β-LAPACHONE;ARQ-501
|
C15H14O3 |
242.27 | |
|
(-)-Epigallocatechin gallate
|
989-51-5 |
(-)-表没食子儿茶素没食子酸酯
|
绿茶的表棒儿茶素;(-)-表没食子儿茶素没食子酸酯(简称EGCG);表没食子儿茶酚没食子酸酯;表没食子儿茶素没食子酸酯 (EGCG);(EGCG)表没食子儿茶素没食子酸酯;表没食子儿茶精3-没食子酸酯;绿茶提取物(98%;(-)-表没食子儿茶素没食子酸酯水合物
|
C22H18O11 |
458.37 | 479-560-7 |
|
3-[N,N-Bis(2-hydroxyethyl)amino]-2-hydroxy-1-propanesulfonic acid
|
68399-80-4 |
3-[N,N-二(羟乙基)氨基]-2-羟基丙磺酸
|
3-[N,N-二(羟乙基)氨基]-2-羟基丙磺酸,超纯级;DIPSO,游离酸;2-羟基-3-[双(2-羟乙基)氨基]丙烷-1-磺酸;3-[N,N-双(2-羟乙基)氨基]-2-羟基丙烷磺酸;羟乙基氨基羟基丙磺酸;3-(N-N-双(2-羟乙基)氨基)-2-羟基丙磺酸,游离酸;DIPSO缓冲液;DIPSO BUFFER(DIPSO缓冲液),0.2M,PH8.5
|
C7H17NO6S |
243.28 | 269-992-2 |
|
Roflumilast
|
162401-32-3 |
罗氟司特
|
罗氟司特(标准品);罗氟斯特;3-(环丙基甲氧基)-N-(3,5-二氯-4-吡啶基)-4-(二氟甲氧基)苯甲酰胺;罗氟司特;ROFLUMILAST;3-(环丙甲氧基)-N-(3,5-二氯-4-吡啶基)-4-(二氟甲氧基)苯甲酰胺;3-(环丙基甲氧基)-N-(3,5-二氯吡啶-4-基)-4-(二氟甲氧基)苯甲酰胺;罗氟司特;3-(环丙甲氧基)-N-(3,5-二氯-4-吡啶基)-5-(二氟甲氧基)苯甲酰胺
|
C17H14Cl2F2N2O3 |
403.207466 | 685-382-2 |
|
N-Cyclohexyl-3-aminopropanesulfonic acid
|
1135-40-6 |
3-(环己胺)-1-丙磺酸
|
3-(环已胺)-1-丙磺酸,超纯级;3-(环已胺)-1-丙磺酸;CAPS;3-(环己氨基)-1-丙烷磺酸;3-(环己胺)-1-丙磺酸;3-环己基氨基丙烷磺酸[生物研究用GOOD'S缓冲液中的成分];3-(环己胺)-1-丙磺酸,99%;3-环己氨基丙磺酸(HEPES)
|
C9H19NO3S |
221.32 | 214-492-1 |
药智官方微信
药智官方微博
